blood disorders

Sanofi acquires Bioverativ Inc., a biopharmaceutical company focused on therapies for hemophilia and other rare blood disorders

Expands Sanofi’s presence in specialty care and strengthens leadership in rare diseases  Adds leader in the growing hemophilia market and…

6 years ago

£34.7 million scheme to create better outcomes for patients with blood disorders

A new project involving Newcastle University experts aims to create better outcomes for patients with blood disorders. NEWCASTLE, 10-Jan-2017 —…

7 years ago